Zentek to delist from Nasdaq, board decides to focus resources on Albany project

Zentek Ltd. provided a corporate update on its Nasdaq listing, saying that although Nasdaq had granted the company's request for continued listing, the board concluded its capital and management resources are better directed toward advancing the Albany project, developing routes to market, and progressing its subsidiary Triera Biosciences.

Detected & updated continuously · Source: Nebula